Androgen receptor signaling in circulating tumor cells as a marker of hormonally responsive prostate cancer

Androgen deprivation therapy (ADT) is initially effective in treating metastatic prostate cancer, and secondary hormonal therapies are being tested to suppress androgen receptor (AR) reactivation in castration-resistant prostate cancer (CRPC). Despite variable responses to AR pathway inhibitors in C...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Miyamoto, David T., Lee, Richard J., Stott, Shannon L., Ting, David T., Wittner, Ben S., Ulman, Matthew, Smas, Malgorzata E., Lord, Jenna B., Brannigan, Brian W., Trautwein, Julie, Bander, Neil H., Wu, Chin-Lee, Sequist, Lecia V., Smith, Matthew R., Ramaswamy, Sridhar, Toner, Mehmet, Maheswaran, Shyamala, Haber, Daniel A.
Formato: Artigo
Idioma:Inglês
Publicado em: 2012
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3508523/
https://ncbi.nlm.nih.gov/pubmed/23093251
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/2159-8290.CD-12-0222
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados